Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials.

Kates M, Matoso A, Choi W, Baras AS, Daniels MJ, Lombardo K, Brant A, Mikkilineni N, McConkey DJ, Kamat AM, Svatek RS, Porten SP, Meeks JJ, Lerner SP, Dinney CP, Black PC, McKiernan JM, Anderson C, Drake CG, Bivalacqua TJ.

Clin Cancer Res. 2020 Feb 15;26(4):882-891. doi: 10.1158/1078-0432.CCR-19-1920. Epub 2019 Nov 11.

PMID:
31712383
2.

Use of the Quick Sequential Organ Failure Assessment Score for Prediction of Intensive Care Unit Admission Due to Septic Shock after Percutaneous Nephrolithotomy: A Multicenter Study.

Yaghoubian A, Batter T, Mozafarpour S, Sacco D, Chew BH, Monga M, Krambeck A, Sur R, Knudsen B, Mikkilineni N, Shah O, Stern K, De S, Miller N, Broutian T, Sourial M, Large T, Scotland K, Lundeen C, Lange D, DiPina T, Bechis SK, Eisner BH; Edge Research Consortium.

J Urol. 2019 Aug;202(2):314-318. doi: 10.1097/JU.0000000000000195. Epub 2019 Jul 8.

PMID:
30829131
3.

Misinformation on the Internet regarding Ablative Therapies for Prostate Cancer.

Asafu-Adjei D, Mikkilineni N, Sebesta E, Hyams E.

Urology. 2019 Nov;133:182-186. doi: 10.1016/j.urology.2018.12.050. Epub 2019 Feb 26.

PMID:
30817959
4.

Prospective Evaluation of Unprocessed Core Needle Biopsy DNA and RNA Yield from Lung, Liver, and Kidney Tumors: Implications for Cancer Genomics.

Silk MT, Mikkilineni N, Silk TC, Zabor EC, Ostrovnaya I, Hakimi AA, Hsieh JJ, Ziv E, Rekhtman N, Solomon SB, Durack JC.

Anal Cell Pathol (Amst). 2018 Dec 10;2018:2898962. doi: 10.1155/2018/2898962. eCollection 2018.

5.

The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling.

Sankin A, Hakimi AA, Mikkilineni N, Ostrovnaya I, Silk MT, Liang Y, Mano R, Chevinsky M, Motzer RJ, Solomon SB, Cheng EH, Durack JC, Coleman JA, Russo P, Hsieh JJ.

Cancer Med. 2014 Dec;3(6):1485-92. doi: 10.1002/cam4.293. Epub 2014 Aug 14.

6.

Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma.

Hakimi AA, Mano R, Ciriello G, Gonen M, Mikkilineni N, Sfakianos JP, Kim PH, Motzer RJ, Russo P, Reuter VE, Hsieh JJ, Ostrovnaya I.

J Urol. 2014 Jul;192(1):24-9. doi: 10.1016/j.juro.2014.01.088. Epub 2014 Feb 8.

Supplemental Content

Loading ...
Support Center